Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Xencor Inc (NQ: XNCR ) 20.25 -0.21 (-1.03%) Streaming Delayed Price Updated: 4:00 PM EDT, Sep 27, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 433,410 Open 20.68 Bid (Size) 20.07 (10) Ask (Size) 20.67 (10) Prev. Close 20.46 Today's Range 20.06 - 20.89 52wk Range 15.31 - 26.84 Shares Outstanding 59,924,016 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Xencor Stock: A Deep Dive Into Analyst Perspectives (4 Ratings) September 26, 2024 Via Benzinga Xencor Announces Closing of Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares September 12, 2024 From Xencor, Inc. Via Business Wire Performance YTD -10.04% -10.04% 1 Month +19.54% +19.54% 3 Month +6.97% +6.97% 6 Month -7.62% -7.62% 1 Year -1.22% -1.22% More News Read More Xencor Announces Pricing of $175 Million Public Offering of Common Stock September 11, 2024 From Xencor, Inc. Via Business Wire Decoding 5 Analyst Evaluations For Xencor July 31, 2024 Via Benzinga Peeling Back The Layers: Exploring Xencor Through Analyst Insights June 14, 2024 Via Benzinga Decoding 6 Analyst Evaluations For Xencor May 10, 2024 Via Benzinga Analyst Scoreboard: 6 Ratings For Xencor April 16, 2024 Via Benzinga Xencor Announces Proposed Public Offering of Common Stock September 10, 2024 From Xencor, Inc. Via Business Wire Xencor Announces XmAb Drug Candidates in Autoimmune Disease with Near-Term Clinical Plans and Shares Clinical Progress in Early-Stage Oncology Programs September 09, 2024 From Xencor, Inc. Via Business Wire Xencor to Host Research & Development Webcast and Conference Call on Monday, September 9, 2024 September 06, 2024 From Xencor, Inc. Via Business Wire Unveiling 4 Analyst Insights On Xencor February 28, 2024 Via Benzinga Recap: Xencor Q4 Earnings February 27, 2024 Via Benzinga Earnings Scheduled For February 27, 2024 February 27, 2024 Via Benzinga XNCR Stock Earnings: Xencor Misses EPS, Beats Revenue for Q2 2024 August 05, 2024 Via InvestorPlace Xencor Reports Second Quarter 2024 Financial Results August 05, 2024 From Xencor, Inc. Via Business Wire Xencor Regains CD20 x CD3 Bispecific T-Cell Engager June 13, 2024 From Xencor, Inc. Via Business Wire XNCR Stock Earnings: Xencor Misses EPS, Misses Revenue for Q1 2024 May 09, 2024 Via InvestorPlace Earnings Preview: Xencor February 26, 2024 Via Benzinga Navigating 4 Analyst Ratings For Xencor January 22, 2024 Via Benzinga Xencor Reports First Quarter 2024 Financial Results May 09, 2024 From Xencor, Inc. Via Business Wire Xencor Appoints Bart Cornelissen as Chief Financial Officer April 09, 2024 From Xencor, Inc. Via Business Wire Xencor to Present at Upcoming Investor Conferences February 28, 2024 From Xencor, Inc. Via Business Wire Xencor Reports Fourth Quarter and Full Year 2023 Financial Results February 27, 2024 From Xencor, Inc. Via Business Wire Xencor to Host Webcast to Review Fourth Quarter and Full Year 2023 Financial Results and Provide Vudalimab Clinical Update February 20, 2024 From Xencor, Inc. Via Business Wire Xencor to Present at the 42nd Annual J.P. Morgan Healthcare Conference January 03, 2024 From Xencor, Inc. Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.